These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28697759)

  • 41. Loss of Dnmt3a and endogenous Kras(G12D/+) cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis.
    Chang YI; You X; Kong G; Ranheim EA; Wang J; Du J; Liu Y; Zhou Y; Ryu MJ; Zhang J
    Leukemia; 2015 Sep; 29(9):1847-56. PubMed ID: 25801914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
    Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
    Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ASXL1 and SETBP1 mutations promote leukaemogenesis by repressing TGFβ pathway genes through histone deacetylation.
    Saika M; Inoue D; Nagase R; Sato N; Tsuchiya A; Yabushita T; Kitamura T; Goyama S
    Sci Rep; 2018 Oct; 8(1):15873. PubMed ID: 30367089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels.
    Inoue D; Matsumoto M; Nagase R; Saika M; Fujino T; Nakayama KI; Kitamura T
    Exp Hematol; 2016 Mar; 44(3):172-6.e1. PubMed ID: 26700326
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The nuclear receptor corepressor NCoR1 regulates hematopoiesis and leukemogenesis in vivo.
    Wan X; Liu L; Zhou P; Hui X; He Q; Yu F; Zhang W; Ding X; Yuan X; Zhang N; Zhao Y; Zhu R; Liu Y; Hao P; Auwerx J; Song X; Leng Q; Zhang Y
    Blood Adv; 2019 Feb; 3(4):644-657. PubMed ID: 30804018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia.
    Wang C; Sashida G; Saraya A; Ishiga R; Koide S; Oshima M; Isono K; Koseki H; Iwama A
    Blood; 2014 May; 123(21):3336-43. PubMed ID: 24735968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.
    Hsu YC; Chen TC; Lin CC; Yuan CT; Hsu CL; Hou HA; Kao CJ; Chuang PH; Chen YR; Chou WC; Tien HF
    Blood Adv; 2019 Aug; 3(15):2355-2367. PubMed ID: 31395598
    [No Abstract]   [Full Text] [Related]  

  • 48. A knock-in Npm1 mutation in mice results in myeloproliferation and implies a perturbation in hematopoietic microenvironment.
    Chou SH; Ko BS; Chiou JS; Hsu YC; Tsai MH; Chiu YC; Yu IS; Lin SW; Hou HA; Kuo YY; Lin HM; Wu MF; Chou WC; Tien HF
    PLoS One; 2012; 7(11):e49769. PubMed ID: 23226219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
    Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D
    Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.
    Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D
    Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mapping of MN1 sequences necessary for myeloid transformation.
    Kandilci A; Surtel J; Janke L; Neale G; Terranova S; Grosveld GC
    PLoS One; 2013; 8(4):e61706. PubMed ID: 23626719
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
    Carella C; Bonten J; Rehg J; Grosveld GC
    Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of Asxl2 leads to myeloid malignancies in mice.
    Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
    Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hematopoietic defects in response to reduced Arhgap21.
    Xavier-Ferrucio J; Ricon L; Vieira K; Longhini AL; Lazarini M; Bigarella CL; Franchi G; Krause DS; Saad STO
    Stem Cell Res; 2018 Jan; 26():17-27. PubMed ID: 29212046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
    Zhang YL; Sun JW; Xie YY; Zhou Y; Liu P; Song JC; Xu CH; Wang L; Liu D; Xu AN; Chen Z; Chen SJ; Sun XJ; Huang QH
    Cell Res; 2018 Apr; 28(4):476-490. PubMed ID: 29531312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ASXL1/2 mutations and myeloid malignancies.
    Medina EA; Delma CR; Yang FC
    J Hematol Oncol; 2022 Sep; 15(1):127. PubMed ID: 36068610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ASXL1 mutation in clonal hematopoiesis.
    Fujino T; Kitamura T
    Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.
    Chen TH; Kambal A; Krysiak K; Walshauser MA; Raju G; Tibbitts JF; Walter MJ
    Blood; 2011 Feb; 117(5):1530-9. PubMed ID: 21123823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.
    Zhang J; Wang J; Liu Y; Sidik H; Young KH; Lodish HF; Fleming MD
    Blood; 2009 Feb; 113(6):1304-14. PubMed ID: 19066392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.